QLT is dedicated to developing innovative ocular products. We intend to commercialize these products ourselves in North America and strive to deliver meaningful return to our shareholders as our current development products reach the market over the next 10 years. We will seek to become a top-tier ophthalmology company based on our development innovation, strong commercial presence, and focus on ocular drugs and devices.
Bob Butchofsky
President and CEO | 
